BRPI0407056A - Composição estabilizada, e precursora, composto radiofarmacêutico, kit e método para a preparação do mesmo, uso do composto radiofarmacêutico, e, método de formação de imagem diagnóstica do corpo de mamìfero - Google Patents

Composição estabilizada, e precursora, composto radiofarmacêutico, kit e método para a preparação do mesmo, uso do composto radiofarmacêutico, e, método de formação de imagem diagnóstica do corpo de mamìfero

Info

Publication number
BRPI0407056A
BRPI0407056A BR0407056-9A BRPI0407056A BRPI0407056A BR PI0407056 A BRPI0407056 A BR PI0407056A BR PI0407056 A BRPI0407056 A BR PI0407056A BR PI0407056 A BRPI0407056 A BR PI0407056A
Authority
BR
Brazil
Prior art keywords
radiopharmaceutical compound
preparation
kit
precursor composition
diagnostic imaging
Prior art date
Application number
BR0407056-9A
Other languages
English (en)
Inventor
David Mcgill
Ingrid Henriksen
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of BRPI0407056A publication Critical patent/BRPI0407056A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSIçãO ESTABILIZADA, E PERCURSORA, COMPOSTO RADIOFARMACêUTICO, KIT E MéTODO PARA A PREPARAçãO DO MESMO, USO DO COMPOSTO RADIOFARMACêUTICO, E, MéTODO DE FORMAçãO DE IMAGEM DIAGNóSTICA DO CORPO DE MAMìFERO" A presente invenção refere-se a composições de complexo metálicas de tecnécio e rênio, estabilizadas, compreendendo um radioprotetor e um complexo de radiometal de um conjugado de agente quelante tetradentado-tropano, em que o complexo de radiometal é neutro. São também descritos compostos radiofarmacêuticos, compreendendo as composições de complexo metálicas estabilizadas, e kits para a preparação dos compostos radiofarmacêuticos
BR0407056-9A 2003-02-07 2004-02-09 Composição estabilizada, e precursora, composto radiofarmacêutico, kit e método para a preparação do mesmo, uso do composto radiofarmacêutico, e, método de formação de imagem diagnóstica do corpo de mamìfero BRPI0407056A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03002809A EP1444990A1 (en) 2003-02-07 2003-02-07 Improved Radiometal Complex Compositions
PCT/GB2004/000443 WO2004069285A1 (en) 2003-02-07 2004-02-09 Improved radiometal complex compositions

Publications (1)

Publication Number Publication Date
BRPI0407056A true BRPI0407056A (pt) 2006-01-17

Family

ID=32605351

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0407056-9A BRPI0407056A (pt) 2003-02-07 2004-02-09 Composição estabilizada, e precursora, composto radiofarmacêutico, kit e método para a preparação do mesmo, uso do composto radiofarmacêutico, e, método de formação de imagem diagnóstica do corpo de mamìfero

Country Status (16)

Country Link
US (1) US20070020177A1 (pt)
EP (2) EP1444990A1 (pt)
JP (2) JP2006528205A (pt)
KR (1) KR20050103221A (pt)
CN (1) CN100548387C (pt)
AT (1) ATE487498T1 (pt)
AU (1) AU2004210191B2 (pt)
BR (1) BRPI0407056A (pt)
CA (1) CA2514307A1 (pt)
DE (1) DE602004029983D1 (pt)
ES (1) ES2355100T3 (pt)
MX (1) MXPA05008356A (pt)
NO (1) NO20053754L (pt)
RU (1) RU2005123799A (pt)
WO (1) WO2004069285A1 (pt)
ZA (1) ZA200506728B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1444990A1 (en) * 2003-02-07 2004-08-11 Amersham plc Improved Radiometal Complex Compositions
US8741261B2 (en) * 2003-12-18 2014-06-03 Ge Healthcare Limited Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
WO2006134424A2 (en) * 2004-12-03 2006-12-21 Ge Healthcare Limited Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled acids by photo-induced free radical carbonylation
GB0428020D0 (en) 2004-12-22 2005-01-26 Amersham Health As Stabilisation of radiopharmaceutical precursors
ES2386364T3 (es) * 2005-02-01 2012-08-17 Ge Healthcare Limited Procedimiento de uso de monóxido de carbono [11C] en la síntesis de marcado de compuestos marcados por 11C por carbonilación de radical libre inducida térmicamente
EP1863749A2 (en) * 2005-03-22 2007-12-12 GE Healthcare Limited Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via ketene using diazo compounds and carbon-isotope monoxide
CN101198359B (zh) * 2005-06-14 2011-06-22 日本医事物理股份有限公司 放射性诊断成像剂
EP1934160B1 (en) * 2005-08-31 2014-07-23 GE Healthcare Limited Method for the use of [11c]carbon monoxide in labeling synthesis of 11c-labelled ketones by photo-induced free radical carbonylation
JPWO2008056481A1 (ja) * 2006-11-09 2010-02-25 日本メジフィジックス株式会社 放射性画像診断剤
GB0922023D0 (en) * 2009-12-17 2010-02-03 Ge Healthcare Ltd Preparation of n-monofluoroalkyl compounds
US9951324B2 (en) 2010-02-25 2018-04-24 Purdue Research Foundation PSMA binding ligand-linker conjugates and methods for using
CN107362376A (zh) * 2010-07-27 2017-11-21 通用电气健康护理有限公司 放射性药物组合物
CN108042811A (zh) * 2012-11-15 2018-05-18 恩多塞特公司 用于治疗由psma表达细胞引起的疾病的共轭物
AU2014216515A1 (en) * 2013-02-15 2015-10-08 Thomas Jefferson University Kit for tumor imaging
LT4095130T (lt) 2013-10-18 2024-04-25 Novartis Ag Žymėti prostatos specifinio membranos antigeno (psma) inhibitoriai, jų naudojimas kaip vizualizavimo medžiagų ir farmacinių medžiagų prostatos vėžiui gydyti
US20150375901A1 (en) * 2014-06-30 2015-12-31 Karen J. Orlich Reusable, eco-friendly container for storing and dispensing food and beverage
US10188759B2 (en) 2015-01-07 2019-01-29 Endocyte, Inc. Conjugates for imaging
RU2624237C1 (ru) * 2016-10-26 2017-07-03 Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации - Федеральный медицинский биофизический центр имени А.И. Бурназяна" Радиофармацевтическая композиция для радиосиновэктомии и способ ее получения
US10486160B2 (en) 2017-08-21 2019-11-26 Bliss Industries, Llc Method of replacing hammers and spacers
USD905136S1 (en) 2018-03-05 2020-12-15 Bliss Industries, Llc Hammermill hammer
US10610870B2 (en) 2017-08-21 2020-04-07 Bliss Industries, Llc Hot and cold forming hammer and method of assembly
US10207274B1 (en) 2017-08-21 2019-02-19 Roger Young Non-forged hammermill hammer
US10478824B2 (en) 2017-08-21 2019-11-19 Bliss Industries, Llc System and method for installing hammers
USD861048S1 (en) 2017-12-06 2019-09-24 Roger Young Swing hammer
USD840447S1 (en) 2017-12-06 2019-02-12 Roger Young Swing hammer
USD839934S1 (en) 2017-12-06 2019-02-05 Roger Young Swing hammer
WO2022156908A1 (en) * 2021-01-25 2022-07-28 Vrije Universiteit Brussel Method for preparing a lyophilized composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents
US4497744A (en) * 1978-03-31 1985-02-05 Mallinckrodt, Inc. Gentisic acid salts as radiographic scanning agent stabilizers
US4233284A (en) * 1978-03-31 1980-11-11 The Procter & Gamble Company Stabilized radiographic scanning agents
DE3274621D1 (en) * 1981-10-30 1987-01-22 Amersham Int Plc Radiopharmaceutical composition based on technetium-99m and reagent for making it
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US7105678B2 (en) * 1995-11-03 2006-09-12 Organix, Inc. Boat tropanes
US6171576B1 (en) * 1995-11-03 2001-01-09 Organix Inc. Dopamine transporter imaging agent
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
US20020111486A1 (en) * 1999-12-03 2002-08-15 Tamagnan Gilles Denis Transition metal-cyclopentadienyl-tropane conjugates
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
FR2833952B1 (fr) 2001-12-26 2004-03-26 Schering Ag Derive du tropane, produit de chelation comprenant ce derive de tropane et un metal ou un complexe de metal et radiopharmaceutique
EP1444990A1 (en) * 2003-02-07 2004-08-11 Amersham plc Improved Radiometal Complex Compositions

Also Published As

Publication number Publication date
ZA200506728B (en) 2006-10-25
AU2004210191A1 (en) 2004-08-19
MXPA05008356A (es) 2006-03-13
ES2355100T3 (es) 2011-03-22
AU2004210191B2 (en) 2007-08-23
NO20053754D0 (no) 2005-08-05
CA2514307A1 (en) 2004-08-19
JP2011132258A (ja) 2011-07-07
EP1590007B1 (en) 2010-11-10
JP2006528205A (ja) 2006-12-14
ATE487498T1 (de) 2010-11-15
CN100548387C (zh) 2009-10-14
NO20053754L (no) 2005-10-05
CN1767859A (zh) 2006-05-03
EP1590007A1 (en) 2005-11-02
WO2004069285A1 (en) 2004-08-19
DE602004029983D1 (de) 2010-12-23
US20070020177A1 (en) 2007-01-25
KR20050103221A (ko) 2005-10-27
EP1444990A1 (en) 2004-08-11
RU2005123799A (ru) 2006-03-27

Similar Documents

Publication Publication Date Title
BRPI0407056A (pt) Composição estabilizada, e precursora, composto radiofarmacêutico, kit e método para a preparação do mesmo, uso do composto radiofarmacêutico, e, método de formação de imagem diagnóstica do corpo de mamìfero
IL175667A (en) Imaging factor that includes a synthetic caspase-3 inhibitor marked with the neuroimaging agent, a radiopharmaceutical containing it, a kit for preparation of the preparation and a method for diagnosis based on it
DE60140219D1 (de) Radiopharmazeutische formulierungen
NO20051811L (no) Conjugates of TC complexes and targeting moiettes and their use in mri diagnostic
BR0210713A (pt) Processo para a produção de um traçador 18f-rotulado, composto, kit radiofarmacêutico, cartucho para um kit radiofarmacêutico, e, método para obtenção de uma imagem de pet diagnóstica
BRPI0515894A (pt) agente de formação de imagem, composições farmacêutica e radiofarmacêutica, conjugado de um inibidor de metaloproteinase matricial com um ligando, precursor para a preparação da composição radiofarmacêutica, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem
AU3602795A (en) Tc or re radiolabelled somatostatin analogs
CO5700829A2 (es) Derivados triciclicos de indol y su uso en eltratamiento de la enfermedad de alzheimer
IL159388A0 (en) Improved chelator conjugates
JP2004529884A5 (pt)
EA200901142A1 (ru) 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
WO2008082695A3 (en) Methods and agents for preparing 18f-radiolabeled fluorinating agents
ATE556722T1 (de) Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs
WO2007088129A3 (en) Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BR9809785A (pt) Composto de ligação de receptor de calcitonina, reagente, agente de formação de imagem cintigráfica, composição, agente radio-terapêutico, complexo, kit para preparar uma preparação radio-farmacêutica, processos para rotular o reagente, para fabricar o reagente, e, uso do reagente
EP1518561A3 (en) Dopamine transporter imaging agents
BR9910468A (pt) Composto, complexo radiometálico, preparação para administração em ser humano, kit, usos de um composto e de um complexo radiometálico do composto, e, fragmento de peptìdeo
WO2006037988A3 (en) Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals
WO2005120584A3 (en) Radiolabeled arylsulfonyl compounds and uses thereof
WO2001080906A3 (en) Radiometal complexes of 2-pyrrolylthiones for imaging a therapy
WO1997033627A3 (en) New ternary radiopharmaceutical complexes
WO2003027148A8 (en) Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging
DK0750610T3 (da) Piperidyl-4-substituerede tyrosinderivater som scintigrafiske billedfrembringende midler til diagnose af thrombose
ATE255586T1 (de) Chelatiermittel für radioimmunotherapie

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.